FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Ranitidine Tablets/Capsules
Status: Discontinuation
»Therapeutic Categories: Gastroenterology; Pediatric

Expand all

Ajanta Pharma USA Inc (Revised 04/03/2020)

Company Contact Information:
855-664-7744

Presentation Posting Date Related Information
150 mg 60’s count bottle (NDC 27241-109-06) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg 500’s count bottle (NDC 27241-109-50) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg 30’s count bottle (NDC 27241-110-03) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg 100’s count bottle (NDC 27241-110-10) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Amneal Pharmaceutical (Revised 04/03/2020)

Company Contact Information:
866-525-7270

Presentation Posting Date Related Information
150 mg, 60 count (NDC 65162-253-06) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, 100 count (NDC 65162-253-10) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, 180 count (NDC 65162-253-18) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, 500 count (NDC 65162-253-50) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, 1000 count (NDC 65162-253-11) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, 1000 count (NDC 65162-253-11) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, 30 count (NDC 65162-254-03) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, 100 count (NDC 65162-254-10) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, 250 count (NDC 65162-254-25) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, 250 count (NDC 53746-254-02) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Appco Pharma LLC (Revised 04/03/2020)

Company Contact Information:
732-253-7735

Presentation Posting Date Related Information
150mg 60 count bottle (NDC 62559-690-60) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150mg 500 count bottle (NDC 62559-690-05) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300mg 30 count bottle (NDC 62559-691-30) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Dr. Reddy's Laboratories, Inc. (Revised 04/03/2020)

Company Contact Information:
866-733-3952

Presentation Posting Date Related Information
150mg 60 count bottle (NDC 5511112960) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150mg 500 count bottle (NDC 5511112905) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300mg 30 count bottle (NDC 5511113030) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300mg 100 count bottle (NDC 5511113001) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Glenmark Pharmaceuticals (Revised 04/03/2020)

Company Contact Information:
888-721-7115

Presentation Posting Date Related Information
150mg 60 count bottle (NDC 68462-248-60) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150mg 100 count bottle (NDC 68462-248-01) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150mg 500 count bottle (NDC 68462-248-05) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300mg 30 count bottle (NDC 68462-249-30) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300mg 100 count bottle (NDC 68462-249-01) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300mg 250 count bottle (NDC 68462-249-20) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Novitium Pharma LLC (Revised 04/03/2020)

Company Contact Information:
609-469-5920

Presentation Posting Date Related Information
150 mg, Bottle of 60 capsules (NDC 70954-001-20) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, Bottle of 500 capsules (NDC 70954-001-40) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, Bottle of 30 capsules (NDC 70954-002-10) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, Bottle of 100 capsule (NDC 70954-002-40) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Sandoz (Revised 04/03/2020)

Company Contact Information:
800-525-8747

Presentation Posting Date Related Information
150 mg 500 ct bottle (NDC 0781-2855-05) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg 60 ct bottle (NDC 0781-2855-60) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg 30 ct bottle (NDC 0781-2865-31) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Strides Pharma Inc. (Revised 04/03/2020)

Company Contact Information:
855-273-0146

Presentation Posting Date Related Information
150 mg, 60 count bottle (NDC 64380-0803-03) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, 100 count bottle (NDC 64380-0803-06) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, 500 count bottle (NDC 64380-0803-07) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
150 mg, 1000 count bottle (NDC 64380-0803-08) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, 30 count bottle (NDC 64380-0804-04) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, 100 count bottle (NDC 64380-0804-06) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market
300 mg, 250 count bottle (NDC 64380-0804-38) 04/03/2020
FDA Requests Removal of All Ranitidine Products (Zantac) from the Market

Teva Pharmaceuticals (New 04/30/2020)

Company Contact Information:
800-545-8800

Presentation Posting Date Related Information
150 mg / 300 mg (NDC 0172-4357-49) and (NDC 0172-4358-46) 04/30/2020 Teva made a business decision to discontinue these products. Teva has not marketed the subject products for an extended period of time.
150 mg/1 unit (NDC 0172-4357-70) 04/30/2020 Teva made a business decision to discontinue these products. Teva has not marketed the subject products for an extended period of time.
300 mg/1 unit (NDC 0172-4358-60) 04/30/2020 Teva made a business decision to discontinue these products. Teva has not marketed the subject products for an extended period of time.

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English